Attached files
file | filename |
---|---|
10-K - FORM 10-K - PALISADE BIO, INC. | f10k_031617p.htm |
EX-32.2 - EXHIBIT 32.2 - PALISADE BIO, INC. | exh_322.htm |
EX-32.1 - EXHIBIT 32.1 - PALISADE BIO, INC. | exh_321.htm |
EX-31.2 - EXHIBIT 31.2 - PALISADE BIO, INC. | exh_312.htm |
EX-31.1 - EXHIBIT 31.1 - PALISADE BIO, INC. | exh_311.htm |
EX-23.02 - EXHIBIT 23.02 - PALISADE BIO, INC. | exh_2302.htm |
EXHIBIT 23.01
Consent Of Independent Registered Public Accounting Firm
Board of Directors and Stockholders
of Neuralstem, Inc.
We consent to the incorporation by reference in the registration statements on Form S-3 (Nos. 333-150574, 333-157079, 333-165973, 333-169847, 333-173221, 333-188859, 333-190936, and 333-196567) and on Form S-8 (Nos. 333-172563 and 333-194881) of Neuralstem, Inc. of our report dated March 23, 2017, with respect to the consolidated balance sheet of Neuralstem, Inc. as of December 31, 2016 and the related consolidated statements of operations and comprehensive loss, changes in stockholders’ equity, and cash flows for the year then ended, which report appears in Neuralstem, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2016.
/s/ Dixon Hughes Goodman LLP
Baltimore, Maryland
March 23, 2017